$2.360
+0.207 (+8.76%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
OVID Prediction & Forecast by Similar Chart Analysis
Alphio's OVID stock price prediction model matches the current Ovid Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.53 (+2.48%). The 1-week path is $2.57 (+4.06%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Ovid Therapeutics Inc Stock?
Ovid Therapeutics is not a good buy right now due to its current price of $2.15, which is significantly below the average analyst price target of $6, suggesting potential upside. However, the stock has experienced a 12.60% decline over the last 5 days and has a very low RSI of 28.869, indicating oversold conditions. The main risk is the negative earnings trend, with a forward P/E of 1.7918, indicating potential challenges in profitability moving forward.
OVID stock price ended at $2.36 on Tuesday, after rising +8.76%
Ovid Therapeutics Inc (OVID) last closed at $2.47, gaining +4.66%. These facts feed the 1-day and 1-week OVID price prediction above.
Analyst Consensus
Ovid Therapeutics Inc (OVID): 4 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Ovid Therapeutics Inc (OVID) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches OVID, ranked by similarity.
Seasonality analysis for OVID
Historically the probability of a positive October return for OVID is 62.30%. September offers the highest probability of a positive month at 67.74%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for OVID
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $0.29 | $0.29 | $0.31 | -88.07% |
| Nov 2026 | $0.23 | $0.27 | $0.30 | -89.22% |
| Dec 2026 | $0.25 | $0.27 | $0.29 | -88.89% |
In 2026, Ovid Therapeutics Inc (OVID) is projected to range from $0.23 to $0.31.
Ovid Therapeutics Inc 2026 monthly forecast
In Oct 2026, Ovid Therapeutics Inc is projected to average $0.29, with a low of $0.29 and high of $0.31.
In Nov 2026, Ovid Therapeutics Inc is projected to average $0.27, with a low of $0.23 and high of $0.30.
In Dec 2026, Ovid Therapeutics Inc is projected to average $0.27, with a low of $0.25 and high of $0.29.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.